ETF Battles ARKG vs. GNOM - What's the better genomic/biotech play?
Send us Fan Mail
Are you ready to go to rumble? In this episode of ETF Battles you'll see a clash between the ARK Genomics Revolution ETF (ARKG) vs. the Global X Genomics & Biotechnology ETF (GNOM). Which ETF is the better play?
Ron DeLegge @ETFguide referees the matchup with guest judges Cinthia Murphy at ETF.com and Dave Kreinces at ETF Portfolio Management providing their research insights.
Each ETF is judged against the other in key categories like cost, exposure strategy, performance and a mystery category. Find out who wins the battle!
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.